HBL Hadasit Bio Holdings logo

HBL Hadasit Bio Holdings

Asia, Yerushalayim, Israel, Jerusalem

Description

HBL Hadasit Bio Holdings is the medical research center of the Hadassah University Hospital.

Investor Profile

HBL Hadasit Bio Holdings has made 3 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series Unknown (100%)

Country Focus

  • Israel (100%)

Industry Focus

  • Biotechnology
  • Medical
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does HBL Hadasit Bio Holdings frequently co-invest with?

Shavit Capital
Asia, Yerushalayim, Israel, Jerusalem
Co-Investments: 1
Peregrine Ventures
Asia, Tel Aviv, Israel, Or Yehuda
Co-Investments: 1
CF
North America, Louisiana, United States, Shreveport
Co-Investments: 1
Dafna Capital Management
North America, California, United States, Los Angeles
Co-Investments: 1
Mirae Asset Venture Investment
Asia, Kyonggi-do, South Korea, Seongnam
Co-Investments: 2
aMoon Fund
Asia, HaMerkaz, Israel, Ra'anana
Co-Investments: 1
Biotechnology Value Fund
North America, California, United States, San Francisco
Co-Investments: 1
Co-Investments: 2
Flerie Invest
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 2
Pavilion Capital
North America, New York, United States, New York
Co-Investments: 2

What are some of recent deals done by HBL Hadasit Bio Holdings?

KAHR medical

Jerusalem, Yerushalayim, Israel

KAHR Medical develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases.

BiotechnologyMedicalPharmaceutical
Series UnknownJun 16, 2021
Amount Raised: $46,500,000
KAHR medical

Jerusalem, Yerushalayim, Israel

KAHR Medical develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases.

BiotechnologyMedicalPharmaceutical
Series UnknownFeb 25, 2020
Amount Raised: $18,000,000
KAHR medical

Jerusalem, Yerushalayim, Israel

KAHR Medical develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases.

BiotechnologyMedicalPharmaceutical
Series UnknownApr 14, 2011
Amount Raised: $3,000,000